TWI323665B - - Google Patents

Download PDF

Info

Publication number: TWI323665B
Authority: TW; Taiwan
Prior art keywords: chitosan; biomedical material; biomedical; nano; film
Prior art date: 2006-07-10

Application number

TW95125098A

Other languages

English (en)

Chinese (zh)

Other versions

TW200803927A (en

Inventor

Shan Hui Hsu

Original Assignee

Nat Univ Chung Hsing

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-10

Filing date

2006-07-10

Publication date

2010-04-21

2006-07-10 Application filed by Nat Univ Chung Hsing filed Critical Nat Univ Chung Hsing

2006-07-10 Priority to TW95125098A priority Critical patent/TW200803927A/zh

2008-01-16 Publication of TW200803927A publication Critical patent/TW200803927A/zh

2010-04-21 Application granted granted Critical

2010-04-21 Publication of TWI323665B publication Critical patent/TWI323665B/zh

Links

229920001661 Chitosan Polymers 0.000 claims description 41
239000000463 material Substances 0.000 claims description 33
239000010931 gold Substances 0.000 claims description 31
239000003519 biomedical and dental material Substances 0.000 claims description 27
210000004027 cell Anatomy 0.000 claims description 26
229910052737 gold Inorganic materials 0.000 claims description 26
208000027418 Wounds and injury Diseases 0.000 claims description 23
206010052428 Wound Diseases 0.000 claims description 19
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 18
239000002105 nanoparticle Substances 0.000 claims description 14
210000005036 nerve Anatomy 0.000 claims description 14
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 13
102000008186 Collagen Human genes 0.000 claims description 10
108010035532 Collagen Proteins 0.000 claims description 10
229920001436 collagen Polymers 0.000 claims description 10
239000011159 matrix material Substances 0.000 claims description 10
230000008929 regeneration Effects 0.000 claims description 10
238000011069 regeneration method Methods 0.000 claims description 10
230000000844 anti-bacterial effect Effects 0.000 claims description 7
239000002245 particle Substances 0.000 claims description 7
230000012010 growth Effects 0.000 claims description 6
230000029663 wound healing Effects 0.000 claims description 6
230000023555 blood coagulation Effects 0.000 claims description 5
230000001737 promoting effect Effects 0.000 claims description 4
210000002569 neuron Anatomy 0.000 claims description 3
239000002861 polymer material Substances 0.000 claims description 3
239000002923 metal particle Substances 0.000 claims 2
239000002159 nanocrystal Substances 0.000 claims 1
210000003491 skin Anatomy 0.000 description 28
239000000523 sample Substances 0.000 description 27
239000000243 solution Substances 0.000 description 25
229910052709 silver Inorganic materials 0.000 description 17
239000004332 silver Substances 0.000 description 17
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
229920002101 Chitin Polymers 0.000 description 13
239000007864 aqueous solution Substances 0.000 description 10
238000006243 chemical reaction Methods 0.000 description 9
210000001519 tissue Anatomy 0.000 description 9
238000000034 method Methods 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
238000011088 calibration curve Methods 0.000 description 6
230000035876 healing Effects 0.000 description 6
208000014674 injury Diseases 0.000 description 6
239000000203 mixture Substances 0.000 description 6
150000003254 radicals Chemical class 0.000 description 6
230000003064 anti-oxidating effect Effects 0.000 description 5
230000006870 function Effects 0.000 description 5
239000007788 liquid Substances 0.000 description 5
229920002683 Glycosaminoglycan Polymers 0.000 description 4
206010061218 Inflammation Diseases 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
238000002835 absorbance Methods 0.000 description 4
230000000740 bleeding effect Effects 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
230000006378 damage Effects 0.000 description 4
239000000975 dye Substances 0.000 description 4
210000002950 fibroblast Anatomy 0.000 description 4
230000001965 increasing effect Effects 0.000 description 4
230000004054 inflammatory process Effects 0.000 description 4
239000000047 product Substances 0.000 description 4
230000028327 secretion Effects 0.000 description 4
239000000126 substance Substances 0.000 description 4
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
238000004630 atomic force microscopy Methods 0.000 description 3
230000012292 cell migration Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000000354 decomposition reaction Methods 0.000 description 3
239000008367 deionised water Substances 0.000 description 3
229910021641 deionized water Inorganic materials 0.000 description 3
230000000694 effects Effects 0.000 description 3
230000028993 immune response Effects 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000008439 repair process Effects 0.000 description 3
MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
241000238421 Arthropoda Species 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
208000032544 Cicatrix Diseases 0.000 description 2
ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
208000005422 Foreign-Body reaction Diseases 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
102000006386 Myelin Proteins Human genes 0.000 description 2
108010083674 Myelin Proteins Proteins 0.000 description 2
206010036790 Productive cough Diseases 0.000 description 2
241000700159 Rattus Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
208000025865 Ulcer Diseases 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
230000000735 allogeneic effect Effects 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
230000003110 anti-inflammatory effect Effects 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000006059 cover glass Substances 0.000 description 2
239000013078 crystal Substances 0.000 description 2
230000006196 deacetylation Effects 0.000 description 2
238000003381 deacetylation reaction Methods 0.000 description 2
230000007547 defect Effects 0.000 description 2
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
238000001035 drying Methods 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
229960002442 glucosamine Drugs 0.000 description 2
210000002767 hepatic artery Anatomy 0.000 description 2
229960002591 hydroxyproline Drugs 0.000 description 2
239000007943 implant Substances 0.000 description 2
238000002513 implantation Methods 0.000 description 2
239000012528 membrane Substances 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
210000005012 myelin Anatomy 0.000 description 2
239000002114 nanocomposite Substances 0.000 description 2
231100000956 nontoxicity Toxicity 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
239000008055 phosphate buffer solution Substances 0.000 description 2
229920000768 polyamine Polymers 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
230000008569 process Effects 0.000 description 2
230000001172 regenerating effect Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
238000010079 rubber tapping Methods 0.000 description 2
231100000241 scar Toxicity 0.000 description 2
230000037387 scars Effects 0.000 description 2
239000001509 sodium citrate Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000012453 sprague-dawley rat model Methods 0.000 description 2
210000003802 sputum Anatomy 0.000 description 2
208000024794 sputum Diseases 0.000 description 2
210000000130 stem cell Anatomy 0.000 description 2
238000003756 stirring Methods 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000017423 tissue regeneration Effects 0.000 description 2
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
230000009466 transformation Effects 0.000 description 2
238000002054 transplantation Methods 0.000 description 2
230000008733 trauma Effects 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
101100008044 Caenorhabditis elegans cut-1 gene Proteins 0.000 description 1
102000012286 Chitinases Human genes 0.000 description 1
108010022172 Chitinases Proteins 0.000 description 1
QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical class ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
239000004365 Protease Substances 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
230000002292 Radical scavenging effect Effects 0.000 description 1
FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
206010072170 Skin wound Diseases 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
239000004280 Sodium formate Substances 0.000 description 1
UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 1
241000700605 Viruses Species 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000000675 anti-caries Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000008952 bacterial invasion Effects 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
ZTHQBROSBNNGPU-UHFFFAOYSA-M butyl sulfate(1-) Chemical compound CCCCOS([O-])(=O)=O ZTHQBROSBNNGPU-UHFFFAOYSA-M 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
238000012993 chemical processing Methods 0.000 description 1
KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
239000004927 clay Substances 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
229960002433 cysteine Drugs 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000007865 diluting Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
229930004069 diterpene Natural products 0.000 description 1
150000004141 diterpene derivatives Chemical class 0.000 description 1
HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
238000012407 engineering method Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
150000004675 formic acid derivatives Chemical class 0.000 description 1
238000002309 gasification Methods 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
230000002440 hepatic effect Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
229910052746 lanthanum Inorganic materials 0.000 description 1
FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
230000036244 malformation Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000012567 medical material Substances 0.000 description 1
239000002609 medium Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000002082 metal nanoparticle Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
210000000944 nerve tissue Anatomy 0.000 description 1
210000001178 neural stem cell Anatomy 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
230000036407 pain Effects 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
244000052769 pathogen Species 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000012466 permeate Substances 0.000 description 1
238000010587 phase diagram Methods 0.000 description 1
INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
210000003240 portal vein Anatomy 0.000 description 1
238000004321 preservation Methods 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000003716 rejuvenation Effects 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
210000003497 sciatic nerve Anatomy 0.000 description 1
238000009991 scouring Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
239000004945 silicone rubber Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
235000019254 sodium formate Nutrition 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
238000010186 staining Methods 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
229940038773 trisodium citrate Drugs 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
230000036269 ulceration Effects 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
239000000052 vinegar Substances 0.000 description 1
235000021419 vinegar Nutrition 0.000 description 1
230000037314 wound repair Effects 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW95125098A 2006-07-10 2006-07-10 A biomedical material TW200803927A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
TW95125098A TW200803927A (en)	2006-07-10	2006-07-10	A biomedical material

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
TW95125098A TW200803927A (en)	2006-07-10	2006-07-10	A biomedical material

Publications (2)

Publication Number	Publication Date
TW200803927A TW200803927A (en)	2008-01-16
TWI323665B true TWI323665B (de)	2010-04-21

Family

ID=44765747

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW95125098A TW200803927A (en)	2006-07-10	2006-07-10	A biomedical material

Country Status (1)

Country	Link
TW (1)	TW200803927A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI414328B (zh) *	2008-09-18	2013-11-11	Nat Health Research Institutes	可植入性神經再生導管

2006
- 2006-07-10 TW TW95125098A patent/TW200803927A/zh unknown

Also Published As

Publication number	Publication date
TW200803927A (en)	2008-01-16

Publication	Publication Date	Title
Zhao et al.	2023	Gold@ Halloysite nanotubes-chitin composite hydrogel with antibacterial and hemostatic activity for wound healing
Mehrabani et al.	2018	Preparation of biocompatible and biodegradable silk fibroin/chitin/silver nanoparticles 3D scaffolds as a bandage for antimicrobial wound dressing
Chhabra et al.	2016	Optimization, characterization, and efficacy evaluation of 2% chitosan scaffold for tissue engineering and wound healing
Nasiri et al.	2022	Fabrication and evaluation of poly (vinyl alcohol)/gelatin fibrous scaffold containing ZnO nanoparticles for skin tissue engineering applications
Teng et al.	2022	Development of tannin-bridged cerium oxide microcubes-chitosan cryogel as a multifunctional wound dressing
CN102702727A (zh)	2012-10-03	一种抗菌复合材料的制备方法
Rani et al.	2015	Evaluation of the antibacterial effect of silver nanoparticles on guided tissue regeneration membrane colonization—An in vitro study
Zhang et al.	2022	Hydrogen plasma treated-Ce-BTC nanorods enable enhanced antibacterial activity and soft tissue sealing ability
CN114392388A (zh)	2022-04-26	一种水凝胶组合物及其应用
CN116920165A (zh)	2023-10-24	一种原位产氧的水凝胶及其制备方法和应用
Wang et al.	2024	Developing a multifunctional gradient pore structure Janus membrane loaded with MB@ ZIF-8 nanoparticles and hydroxyapatite for guided periodontal bone regeneration
CN114716817A (zh)	2022-07-08	一种二氧化铈纳米棒杂化多功能水凝胶、制备方法及应用
Mondal et al.	2024	Development of nano ZnO loaded chitosan-sericin nano-biocomposite-a rapid homeostasis and effective wound healing agent
CN104784744A (zh)	2015-07-22	一种人发角蛋白复合伤口敷料的制备方法
CN118126401A (zh)	2024-06-04	一种天然糖肽水凝胶的制备方法
CN114470342A (zh)	2022-05-13	一种负载ZIF-8的Janus电纺纤维膜的制备方法
Sheng et al.	2025	Cotton gauze fabricated with hydro-stable Zn-MOF enables hemostasis acceleration, antibacterial activity, and wound regeneration
TWI323665B (de)	2010-04-21
CN114874479A (zh)	2022-08-09	一种海绵状大孔水凝胶的制备方法及在抗菌中的应用
CN116370695B (zh)	2025-03-25	一种用于急性出血部位抗炎促愈的可吸收止血复合材料及其制备方法
CN116444992B (zh)	2025-01-24	一种按需降解的促糖尿病创面修复的水凝胶材料及其制备方法与应用
CN117919520A (zh)	2024-04-26	一种引导骨组织再生纳米复合膜及其制备方法和应用
KR20250089647A (ko)	2025-06-19	덴드리머가 결합한 나노세리아 및 젤라틴 하이드로겔을 포함하는 골 재생용 스캐폴드 및 이의 제조방법
CN117323457B (zh)	2024-06-21	一种3d打印创可贴及其制备方法
CN110478521A (zh)	2019-11-22	载药纳米纤维及其制备方法和应用